Summary
Pharmacom Pharma Mix 1, a multi-ingredient injectable blend manufactured by Pharmacom Labs, underwent independent testing to validate its composition and quality. The sample, identified with an expiration date of June 2020, was submitted and funded by AnabolicLab.com. Testing was conducted by SIMEC AG, an ISO-accredited laboratory specializing in pharmaceutical analysis.
The results confirmed the presence and accurate concentrations of the three declared compounds—Testosterone Phenylpropionate, Boldenone Undecylenate, and Testosterone Cypionate. Minor variances from the labeled specifications were noted, all within acceptable ranges. Microbiological tests verified the absence of contamination.
Detailed Report
Product Overview
- Manufacturer: Pharmacom Labs
- Product Name: Pharma Mix 1
- Batch Number: Not specified
- Expiration Date: June 2020
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: C 67095
- Testing Ordered: 28 February 2018
- Sample Received: 28 February 2018
- Analysis Conducted By: SIMEC AG
- Product Submitted By: AnabolicLab.com
- Analysis Paid For By: AnabolicLab.com
Testing Results
| Compound | Specification (Label Claim) | Measured Concentration | Accuracy | Variance | Compliance |
|---|---|---|---|---|---|
| Testosterone Phenylpropionate | 50 mg/ml | 50.9 mg/ml | 101.80% | +1.80% | Yes |
| Boldenone Undecylenate | 200 mg/ml | 196.7 mg/ml | 98.35% | -1.65% | Yes |
| Testosterone Cypionate | 200 mg/ml | 204.7 mg/ml | 102.35% | +2.35% | Yes |
| Microbiological Testing | Result | Specification |
|---|---|---|
| TAMC | <1 KBE/ml | Complies |
| TYMC | <1 KBE/ml | Complies |
Evaluation of Independent Testing
The analysis confirms that Pharmacom Pharma Mix 1 is accurately formulated, with all tested compounds closely aligning with the labeled claims. Minor variances in concentrations are well within acceptable pharmaceutical standards. The absence of microbiological contamination further reinforces the product’s safety and quality.
It is important to note that while this specific batch demonstrated excellent manufacturing consistency, these results pertain solely to the tested sample. Broader validation through independent testing of additional batches is recommended to ensure consistent product quality across the market.
Conclusion
The independent analysis of Pharmacom Pharma Mix 1 confirms its accuracy and adherence to label specifications, with a total absence of microbiological contamination. These results reflect a high-quality pharmaceutical product, but continued independent testing is advised for comprehensive validation and to ensure consistent quality across all batches.
Disclaimer
This report is published for educational and harm reduction purposes. The findings pertain solely to the tested batch and may not represent other products under the same name. Readers are encouraged to cross-reference these results with additional independent testing to ensure informed decision-making.
Discuss the Pharmacom Labs PHARMA Mix 1 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
